Literature DB >> 24381180

Postmenopausal hypertension: role of the sympathetic nervous system in an animal model.

Rodrigo O Maranon1, Roberta Lima, Mohammed Mathbout, Jussara M do Carmo, John E Hall, Richard J Roman, Jane F Reckelhoff.   

Abstract

In postmenopausal women the mechanisms responsible for hypertension have not been completely elucidated, and there are no gender-specific guidelines for women despite studies showing that blood pressure is not as well controlled to goal in women as in men. In the present study we tested the hypotheses that the sympathetic nervous system and the renal sympathetic nerves contribute to hypertension in aging female rats, that sympathetic activation may be mediated by the melanocortin 3/4 receptor (MC3/4R), and that MC3/4R activation may be due to increases in leptin. α-1, β-1,2-Adrenergic blockade reduced blood pressure in both young (3-4 mo) and old (18-19 mo) female spontaneously hypertensive rats (SHR). Renal denervation attenuated the hypertension more in old females than young females. MC3/4R antagonism with SHU-9119 given intracerebroventricularly had no effect on blood pressure in either young or old females but significantly reduced blood pressure in old males. Plasma leptin levels were similar in old male and female SHR and in old versus young females. These data suggest that the hypertension in old female SHR is in part due to activation of the sympathetic nervous system, that the renal nerves contribute to the hypertension, and that the mechanism responsible for sympathetic activation in old females is independent of the MC3/4R.

Entities:  

Keywords:  aging; leptin; melanocortin 3/4 receptor; renal denervation; sex differences

Mesh:

Substances:

Year:  2013        PMID: 24381180      PMCID: PMC3921310          DOI: 10.1152/ajpregu.00490.2013

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  41 in total

Review 1.  New therapeutic approaches to resistant hypertension.

Authors:  Markus P Schlaich; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins.

Authors:  John E Hall; Alexandre A da Silva; Jussara M do Carmo; John Dubinion; Shereen Hamza; Shankar Munusamy; Grant Smith; David E Stec
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

3.  Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

Authors:  Markus P Schlaich; Nora Straznicky; Mariee Grima; Carolina Ika-Sari; Tye Dawood; Felix Mahfoud; Elisabeth Lambert; Reena Chopra; Flora Socratous; Sarah Hennebry; Nina Eikelis; Michael Böhm; Henry Krum; Gavin Lambert; Murray D Esler; Paul A Sobotka
Journal:  J Hypertens       Date:  2011-05       Impact factor: 4.844

4.  Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.

Authors: 
Journal:  Hypertension       Date:  2011-03-14       Impact factor: 10.190

5.  Postmenopausal hypertension: role of 20-HETE.

Authors:  Licy L Yanes; Roberta Lima; Mohadetheh Moulana; Damian G Romero; Kuichang Yuan; Michael J Ryan; Rodney Baker; Huimin Zhang; Fan Fan; Deborah D Davis; Richard J Roman; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

6.  Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats?

Authors:  Wen Qiang Chen; Heng Cai; Cheng Zhang; Xiao Ping Ji; Yun Zhang
Journal:  Hypertens Res       Date:  2010-07-29       Impact factor: 3.872

7.  Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004.

Authors:  Jeffrey A Cutler; Paul D Sorlie; Michael Wolz; Thomas Thom; Larry E Fields; Edward J Roccella
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

8.  Influences of gender on the interaction between sympathetic nerve traffic and central adiposity.

Authors:  Jens Tank; Karsten Heusser; Andre Diedrich; Dagmara Hering; Friedrich C Luft; Andreas Busjahn; Krzysztof Narkiewicz; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

9.  Indices of autonomic nervous system activity in women with mild hypertension in the perimenopausal period.

Authors:  Danuta Czarnecka; Aneta Pośnik-Urbańska; Kalina Kawecka-Jaszcz; Władysława Kolasińska-Kloch; Wiktoria Wojciechowska; Danuta Fedak
Journal:  Kardiol Pol       Date:  2009-03       Impact factor: 3.108

10.  Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study.

Authors:  Duanduan Ma; Mary F Feitosa; Jemma B Wilk; Jason M Laramie; Kai Yu; Catherine Leiendecker-Foster; Richard H Myers; Michael A Province; Ingrid B Borecki
Journal:  Hypertension       Date:  2009-02-09       Impact factor: 10.190

View more
  26 in total

1.  Sex and gender differences in cardiovascular, renal and metabolic diseases.

Authors:  Jane F Reckelhoff; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-07       Impact factor: 3.619

2.  Chronic Estrogen Supplementation Prevents the Increase in Blood Pressure in Female Intrauterine Growth-Restricted Offspring at 12 Months of Age.

Authors:  Gwendolyn K Davis; Ashley D Newsome; Alyssa B Cole; Norma B Ojeda; Barbara T Alexander
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

Review 3.  Androgens and Blood Pressure Control: Sex Differences and Mechanisms.

Authors:  Jane F Reckelhoff
Journal:  Mayo Clin Proc       Date:  2019-01-31       Impact factor: 7.616

4.  The association between resting heart rate and blood pressure among children and adolescents with different waist circumferences.

Authors:  Bin Dong; Zhiqiang Wang; Hai-Jun Wang; Jun Ma
Journal:  Eur J Pediatr       Date:  2014-07-15       Impact factor: 3.183

5.  Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.

Authors:  Danielle N Adank; Mary M Lunzer; Mark D Ericson; Zoe M Koeperich; Stacey L Wilber; Katlyn A Fleming; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2020-09-10       Impact factor: 4.418

6.  AJP-Regulatory, Integrative and Comparative Physiology: Looking Toward the Future.

Authors:  Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-05-06       Impact factor: 3.619

Review 7.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

Review 8.  Gender Differences in Hypertension.

Authors:  Juan-Juan Song; Zheng Ma; Juan Wang; Lin-Xi Chen; Jiu-Chang Zhong
Journal:  J Cardiovasc Transl Res       Date:  2019-05-01       Impact factor: 4.132

Review 9.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

10.  Hypertension and Migraine in the Northern Manhattan Study.

Authors:  Hannah Gardener; Teshamae Monteith; Tatjana Rundek; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.